16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CRISPR-based platform for carbapenemases and emerging viruses detection using Cas12a (Cpf1) effector nuclease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          CRISPR-Cas12a (also called Cpf1) has been commonly used for genomic editing, based on its ability to generate precise double-stranded DNA (dsDNA) breaks. Recently, it was demonstrated that Cas12a exhibits unspecific ssDNAse activity upon target recognition. This feature allows CRISPR-Cas to be coupled with a ssDNA reporter and generate a fast, accurate and ultrasensitive molecular detection method. Here, we demonstrate that Cas12a was able to detect DNA target sequences corresponding to carbapenemases resistance genes such as KPC, NDM and OXA. Also, with the addition of a reverse-transcription step, we were able to detect viral RNA sequences from DENV, ZIKV and HANTV genomes. In all cases, assay run time was less than two hours. Additionally, we report attomolar levels of detection. This methodology was validated using clinical samples from patients infected with Dengue virus. Reactions were visualized by detection of a fluorescent signal, as well as by the use of a simple lateral flow strip. These results indicate that Cas12a is able to detect both DNA and RNA targets, making it an appropriate and convenient tool to detect all types of pathogens.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          CRISPR-Cas12a-assisted nucleic acid detection

          Dear Editor, Today, the need for time-effective and cost-effective nucleic acid detection methods is still growing in fields such as human genotyping and pathogen detection. Using synthetic biomolecular components, many methods have been developed for fast nucleic acid detection 1–3 ; however, they may not be able to satisfy specificity, sensitivity, speed, cost and simplicity at the same time. Recently, a very promising CRISPR-based diagnostic (CRISPR-Dx) (namely SHERLOCK) was established, which was based on the collateral effect of an RNA-guided and RNA-targeting CRISPR effector, Cas13a 4 . SHERLOCK is of high sensitivity and specificity, and is very convenient in detection of target RNA. However, to detect DNA sequences, in vitro transcription of DNA to RNA must be conducted prior to the SHERLOCK test, which could be inconvenient. In a recent study, we found that Cas12a, which belongs to the class 2 type V-A CRISPR-Cas system 5 , performed collateral cleavage on non-targeted ssDNAs upon the formation of the Cas12a/crRNA/target DNA ternary complex 6 . Here, with the employment of this feature, we used a quenched fluorescent ssDNA reporter (e.g., HEX-N12-BHQ1 in Supplementary Table S1) as the probe, and developed HOLMES (an one-HOur Low-cost Multipurpose highly Efficient System), which could be used for fast detection of target DNA as well as target RNA. In HOLMES, if a target DNA exists in the reaction system, the Cas12a/crRNA binary complex forms a ternary complex with the target DNA, which will then trans-cleave non-targeted ssDNA reporter in the system, illuminating the HEX fluorescence (or any other fluorescence) (Fig. 1a). Fig. 1 HOLMES is a rapid, simple and efficient method for nucleic acid detection. a An illustration of HOLMES. To detect a target DNA, specific amplification of the target DNA by either PCR or other isothermal amplification methods will be performed, and a crRNA guide sequence is specially designed, targeting a region in the target DNA. The PAM sequence can be designed on the primers and introduced during amplification. After that, the amplicon was mixed with the Cas12a/crRNA complex, and a ternary complex forms if the target DNA exists. Upon the formation of the ternary complex, the quenched fluorescent ssDNA reporter is trans-cleaved, illuminating the fluorescence. b Comparison of the signal-to-noise values of trans-cleavage by ten Cas12a proteins from different species. The reaction system included Cas12a, crRNA (crRNA-T1), target DNA (pUC18-T1) and quenched fluorescent ssDNA (HEX-N12-BHQ1), and the target DNA was omitted in the negative control. The signal-to-noise values were labeled and values larger than 10 were shown in red (n = 3 technical replicates; bars represent the mean ± SEM). Fn Francisella tularensis; As Acidaminococcus sp. BV3L6; Lb Lachnospiraceae bacterium ND2006; Lb5 Lachnospiraceae bacterium NC2008; HK Helcococcus kunzii ATCC 51366; Os Oribacterium sp. NK2B42; Ts Thiomicrospira sp. XS5; Bb Bacteroidales bacterium KA00251; Bo Bacteroidetes oral taxon 274 str. F0058; Lb4 Lachnospiraceae bacterium MC2017. c Detection sensitivity of Cas12a alone or Cas12a combined with PCR amplification (i.e., HOLMES). Serially diluted pUC18-T1 plasmid was employed as the target dsDNA. (n = 3 technical replicates; bars represent the mean ± SEM). d Schematic of human SNP genotyping by HOLMES. The amplification of a target DNA containing the SNP locus is almost the same as described in Fig. 1a, and design of primers and introduction of the PAM site are detailed in Supplementary Figure S3. To detect an SNP, more than one crRNA is needed, targeting different genotypes. e HOLMES correctly genotyped different human SNP loci in HEK293T, a candidate individual, and the PCR-generated templates (n = 3 technical replicates; two-tailed Student’s t-test; **p < 0.01; ****p < 0.0001; bars represent the mean ± SEM). Genotypes verified by Sanger sequencing were annotated below each plot, and the results of other SNP loci could be found in Supplementary Figure S4a We ever purified ten Cas12a proteins (Supplementary Table S3) and found all showed the ssDNA trans-cleavage activity 6 . To find the most suitable Cas12a for HOLMES (i.e., with high signal-to-noise ratios), we tested all ten Cas12a proteins and found Lachnospiraceae bacterium ND2006 Cas12a (LbCas12a), Oribacterium sp. NK2B42 Cas12a (OsCas12a), Lachnospiraceae bacterium NC2008 Cas12a (Lb5Cas12a) and Francisella tularensis Cas12a (FnCas12a) showed good performance, among which LbCas12a was chosen for the following studies (Fig. 1b). To determine the sensitivity of HOLMES, we titrated target DNA, and found the minimum detectable concentration for Cas12a-crRNA was approximately 0.1 nM; however, when combined with PCR, the detectable concentration could be as low as 10 aM (Fig. 1c), which was comparable to the SHERLOCK system 4 and was better than PCR alone or quantitative PCR using the SYBR Green method (Supplementary Figure S1). Therefore, to achieve higher sensitivity, PCR amplification was employed in the HOLMES test thereafter. To test whether HOLMES could discriminate single-base differences, we made point mutations at different positions in the target DNA sequence, including both the PAM region and the guide sequences (Supplementary Figure S2a). When a full length of crRNA guide sequence (24-nt crRNA, Supplementary Table S2) was used, we found mutations in either the PAM sequences or the region of the 1st–7th bases of the guide sequence resulted in clear decline of the fluorescence signal; however, no significant difference was observed when the mutation was within the region of the 8th–18th bases (Supplementary Figure S2b), which was highly consistent with the previous report that the 5′-end seed region in the crRNA guide sequence was extremely important for Cas12a recognition 7 . In addition, based on our previous findings 8 , Cas12a with a reduced length of crRNA guide sequence showed higher cleavage specificity. Therefore, we then tested shorter guide sequences, and found point mutations within a larger region (1st–16th bases) resulted in more than 2-fold difference in fluorescence signals for both 16-nt and 17-nt crRNA guide sequences (Supplementary Figure S2b), suggesting that shorter guide sequences might be used in HOLMES. Furthermore, considering the fact that there might exist no suitable PAM sequence nearby the SNP site, primers for PCR amplification were specially designed to introduce the PAM sequence (Supplementary Figure S3), which therefore allowed for sequence-independent detection of any single nucleotide polymorphism (SNP) sites. We then chose a dozen of SNP loci that are related to human health and personal characteristics (Supplementary Table S4). We either extracted genomic DNA from cultured human 293T cells or collected saliva from human individuals, and then PCR amplified the target regions, followed by the HOLMES assay to distinguish alleles (Fig. 1d). The results clearly showed that HOLMES had sufficiently high specificity to determine both homozygous and heterozygous genotypes (Fig. 1e and Supplementary Figure S4a). We also collected nineteen volunteers’ saliva samples to detect the SNP rs1014290, which is related to gout risk, and proved that HOLMES could be used to rapidly and easily detect human SNP genotypes (Supplementary Figure S4b). Moreover, HOLMES could also be used to detect DNA viruses (e.g., pseudorabies virus (PRV), Supplementary Figure S5a) and RNA viruses (e.g., Japanese encephalitis virus (JEV), Supplementary Figure S6a), and the sensitivity for both could be as low as 1–10 aM (Supplementary Figures S5b and S6b). For JEV, total RNA was first extracted and then reverse transcribed into cDNA before being detected by HOLMES. Because of the high sensitivity, HOLMES successfully detected PRV virus in both the PRV-infected cells and the culture supernatant (Supplementary Figure S5c). In addition, the high specificity of HOLMES also enabled it to distinguish between virus strains. For example, the PRV Ra classical strain, the cmz variant strain and the Bartha-K61 vaccine strain were easily discriminated by the gE46 site (Supplementary Figure S5d and S5e). Similarly, the JEV NJ2008 strain and the live-attenuated vaccine strain SA14-14-2 were well differentiated by the site E138 (Supplementary Figure S6c and S6d). The “SHERLOCK” nucleic acid detection system was recently established with the employment of the “RNA collateral effect” of Cas13a and an isothermal amplification method 6 . Although both HOLMES and SHERLOCK show attomolar detection sensitivity and can be used to detect both DNA and RNA targets, this study indicates that HOLMES may have advantages in DNA detection, while SHERLOCK is more convenient for RNA detection. In addition, isothermal amplification methods (e.g., the recombinase polymerase amplification (RPA) and loop-mediated isothermal amplification (LAMP)) can also be used although rapid PCR amplification was used in HOLMES in this study. Similar to SHERLOCK, HOLMES requires no expensive reagents and no special instruments, making it low cost and easily accessible for nucleic acid detection. In addition to the medical applications described above, HOLMES may also be used for a variety of applications that require rapid detection of nucleic acids, including monitoring foods and the environment. (While this manuscript has been ready to submit to Cell Discovery, two pieces of work were published on Science, both of which described the use of the Cas12a trans-cleavage activity on ssDNAs for nucleic acid detection 9, 10 .) Electronic supplementary material Supplementary Information
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis

            ABSTRACT Rapid and simple-to-use diagnostic methods for tuberculosis are urgently needed. Recent development has unveiled the diagnostic power of the CRISPR system in the detection of viral infections. However, its potential use in detecting the Mycobacterium tuberculosis complex (MTB) remained unexplored. We developed a rapid CRISPR-based assay for TB detection and conducted a retrospective cohort study of 179 patients to evaluate the CRISPR-MTB test for identifying MTB in various forms of direct clinical samples. Its diagnostic performance was compared, in parallel with culture and the GeneXpert MTB/RIF assay (Xpert). The CRISPR-MTB test is highly sensitive with a near single-copy sensitivity, demands less sample input and offers shorter turnaround time than Xpert. When evaluated in the clinical cohort of both pulmonary and extra-pulmonary tuberculosis, the CRISPR-MTB test exhibited an overall improved sensitivity over both culture (79% vs 33%) and Xpert (79% vs 66%), without comprise in specificity (62/63, 98%). The CRISPR-MTB test exhibits an improved overall diagnostic performance over culture and Xpert across a variety of sample types, and offers great potential as a new diagnostic technique for both pulmonary and extra-pulmonary tuberculosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Isothermal Amplification for MicroRNA Detection: From the Test Tube to the Cell.

              MicroRNAs (miRNAs) are a class of small noncoding RNAs that act as pivotal post-transcriptional regulators of gene expression, thus involving in many fundamental cellular processes such as cell proliferation, migration, and canceration. The detection of miRNAs has attracted significant interest, as abnormal miRNA expression is identified to contribute to serious human diseases such as cancers. Particularly, miRNAs in peripheral blood have recently been recognized as important biomarkers potential for liquid biopsy. Furthermore, as miRNAs are expressed heterogeneously in different cells, investigations into single-cell miRNA expression will be of great value for resolving miRNA-mediated regulatory circuits and the complexity and heterogeneity of miRNA-related diseases. Thus, the development of miRNA detection methods, especially for complex clinic samples and single cells is in great demand. In this Account, we will present recent progress in the design and application of isothermal amplification enabling miRNA detection transition from the test tube to the clinical sample and single cell, which will significantly advance our knowledge of miRNA functions and disease associations, as well as its translation in clinical diagnostics. miRNAs present a huge challenge in detection because of their extremely short length (∼22 nucleotides) and sequence homology (even with only single-nucleotide variation). The conventional golden method for nucleic acid detection, quantitative PCR (qPCR), is not amenable to directly detecting short RNAs and hardly enables distinguishing between miRNA family members with very similar sequences. Alternatively, isothermal amplification has emerged as a powerful method for quantification of nucleic acids and attracts broad interest for utilization in developing miRNA assays. Compared to PCR, isothermal amplification can be performed without precise control of temperature cycling and is well fit for detecting short RNA or DNA. We and other groups are seeking methods based on isothermal amplification for detecting miRNA with high specificity (single-nucleotide resolution) and sensitivity (detection limit reaching femtomolar or even attomolar level). These methods have recently been demonstrated to quantify miRNA in clinical samples (tissues, serum, and plasma). Remarkably, attributed to the mild reaction conditions, isothermal amplification can be performed inside cells, which has recently enabled miRNA detection in single cells. The localized in situ amplification even enables imaging of miRNA at the single-molecule level. The single-cell miRNA profiling data clearly shows that genetically identical cells exhibit significant cell-to-cell variation in miRNA expression. The leap of miRNA detection achievements will significantly contribute to its full clinical adoption and translation and give us new insights into miRNA cellular functions and disease associations.
                Bookmark

                Author and article information

                Journal
                Emerg Microbes Infect
                Emerg Microbes Infect
                Emerging Microbes & Infections
                Taylor & Francis
                2222-1751
                2 June 2020
                2020
                : 9
                : 1
                : 1140-1148
                Affiliations
                [a ]INPA-CONICET- Universidad de Buenos Aires , Argentina
                [b ]CASPR Biotech , San Francisco, CA, USA
                [c ]Facultad de Ciencias Bioquímicas y Farmacéuticas, Departamento de Microbiología, Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET), Universidad Nacional de Rosario , Argentina
                [d ]Laboratorio GIGA, FCEQyN, Instituto de Biología Subtropical, Universidad Nacional de Misiones – CONICET
                Author notes
                [CONTACT ] Carla Alejandra Gimenez carla@ 123456caspr.bio

                Supplemental data for this article can be accessed at https://doi.org/10.1080/22221751.2020.1763857

                Article
                1763857
                10.1080/22221751.2020.1763857
                7448918
                32486913
                1378bd75-6c30-45bd-a6e4-3978fe8c35de
                © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Page count
                Figures: 10, Tables: 0, Equations: 0, References: 23, Pages: 9
                Categories
                Research Article
                Articles

                infectious diseases,molecular diagnostic,crispr/cas12a,rna viruses,antibiotic resistance

                Comments

                Comment on this article